Company intelligence / Profile preview

The GeneLab Bioscience

Ownership: Private
Development stage: Commercial

Overview

The GeneLab Bioscience is a leading Nigerian research and diagnostics laboratory specializing in genomics-driven cancer detection, infectious disease testing, toxicology screens, virology/microbiology services. It offers advanced DNA/RNA sequencing capabilities and has partnered with Oxford Nanopore Technologies to expand genomic access in West Africa. No clinical trial results are reported as it does not develop therapeutics directly.

Therapeutic areas: OtherOncologyInfectious Diseases
Modalities: Biologic (biovaccines)Diagnostic assays (genetic sequencing, biomarker analysis)Cell culture technologiesSequencing technologies (Sanger, Next-generation sequencing)
Industry: Molecular Diagnostics

Partnerships

Oxford Nanopore Technologies

Beyond the preview

Go deeper on The GeneLab Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on The GeneLab Bioscience.

Explore the full profile